Assessing cancer drugs for reimbursement: methodology, relationship between effect size and medical need.

Abstract

Reimbursement is assessed by the Transparency Commission from the Health Authority (HAS) using a medical benefit (SMR) score that gives access to reimbursement, an "improvement of medical service rendered" (ASMR) that determines the added therapeutic value, and the target population. Assessing cancer drugs for reimbursement raises the same issues as other… (More)
DOI: 10.2515/therapie/2010042

1 Figure or Table

Topics

  • Presentations referencing similar topics